Globe Newswire 19,000-square-foot facility reflects the company's recent growth and continued commitment to the regionMORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient...\n more…
Globe Newswire Science 37 Supports Phase 3 Clinical Trial with Recruitment and Enrollment, Enhancing Access for Immunocompromised Patients Across the U.S.MORRISVILLE, N.C., July 18, 2024 (GLOBE NEWSWIRE...\n more…
Globe Newswire Nearly 20 studies have successfully leveraged Science 37's medical and operational expertise to boost patient recruitment and enrollment activitiesRESEARCH TRIANGLE PARK, N.C., June 27, 2024 (GLOBE...\n more…
Globe Newswire Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional Research Sites Through its Virtual Site and Patient Recruitment SolutionsRESEARCH TRIANGLE PARK, N.C., June 12, 2024...\n more…
Globe Newswire Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial...\n more…
Globe Newswire Science 37's Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA InspectionRESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today...\n more…